Woodline Partners LP Biomea Fusion, Inc. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 240,844 shares of BMEA stock, worth $397,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
240,844
Previous 240,844
-0.0%
Holding current value
$397,392
Previous $934,000
45.18%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BMEA
# of Institutions
107Shares Held
16.8MCall Options Held
237KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.89 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.1 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.3MShares$2.15 Million1.27% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.32 Million0.59% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.3M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...